Kent W. Mouw

Kent W. Mouw is an Assistant Professor of Radiation Oncology at Harvard Medical School and Co-Director of the Bladder Cancer Center. He is affiliated with Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School. His clinical expertise focuses on genitourinary cancers, including bladder, prostate, kidney, and testicular cancers.

Education:

• Medical School: University of Chicago
• Residency: Harvard Radiation Oncology Program

Research Interests: Dr. Mouw's laboratory investigates DNA repair pathway alterations in tumor biology, with a focus on developing novel therapies (e.g., PARP inhibitors, immunotherapy) and biomarkers to guide treatment decisions. His work integrates genomic and functional approaches to advance precision medicine in genitourinary cancers.

Labs/Teams: He leads the Mouw Lab, a collaborative team of cancer biologists and oncologists at Dana-Farber Cancer Institute, dedicated to translating genomic insights into clinical applications.